144 related articles for article (PubMed ID: 19678823)
1. Therapeutic efficacy of Bifidobacterium longum-mediated human granulocyte colony-stimulating factor and/or endostatin combined with cyclophosphamide in mouse-transplanted tumors.
Zhu LP; Yin Y; Xing J; Li C; Kou L; Hu B; Wu ZW; Wang JJ; Xu GX
Cancer Sci; 2009 Oct; 100(10):1986-90. PubMed ID: 19678823
[TBL] [Abstract][Full Text] [Related]
2. Bifidobacterium longum as a delivery system of TRAIL and endostatin cooperates with chemotherapeutic drugs to inhibit hypoxic tumor growth.
Hu B; Kou L; Li C; Zhu LP; Fan YR; Wu ZW; Wang JJ; Xu GX
Cancer Gene Ther; 2009 Aug; 16(8):655-63. PubMed ID: 19229287
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of Bifidobacterium longum-mediated human interleukin-2 with endostatin or TRAIL in transplanted tumors in mice.
Yin Y; Kou L; Wang JJ; Xu GX
Exp Ther Med; 2012 Mar; 3(3):481-486. PubMed ID: 22969915
[TBL] [Abstract][Full Text] [Related]
4. A new expression plasmid in Bifidobacterium longum as a delivery system of endostatin for cancer gene therapy.
Xu YF; Zhu LP; Hu B; Fu GF; Zhang HY; Wang JJ; Xu GX
Cancer Gene Ther; 2007 Feb; 14(2):151-7. PubMed ID: 17068487
[TBL] [Abstract][Full Text] [Related]
5. Selenium-Bifidobacterium longum as a delivery system of endostatin for inhibition of pathogenic bacteria and selective regression of solid tumor.
Li C; Chen X; Kou L; Hu B; Zhu LP; Fan YR; Wu ZW; Wang JJ; Xu GX
Exp Ther Med; 2010 Jan; 1(1):129-135. PubMed ID: 23136605
[TBL] [Abstract][Full Text] [Related]
6. Preparation of selenium-enriched Bifidobacterium longum and its effect on tumor growth and immune function of tumor-bearing mice.
Yin Y; Wang RR; Wang Y; Wang JJ; Xu GX
Asian Pac J Cancer Prev; 2014; 15(8):3681-6. PubMed ID: 24870777
[TBL] [Abstract][Full Text] [Related]
7. Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer.
Fu GF; Li X; Hou YY; Fan YR; Liu WH; Xu GX
Cancer Gene Ther; 2005 Feb; 12(2):133-40. PubMed ID: 15565182
[TBL] [Abstract][Full Text] [Related]
8. Genetically engineered Bifidobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats.
Sasaki T; Fujimori M; Hamaji Y; Hama Y; Ito K; Amano J; Taniguchi S
Cancer Sci; 2006 Jul; 97(7):649-57. PubMed ID: 16827806
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of pro‑ and anti‑tumor effects induced by three colony‑stimulating factors, G‑CSF, GM‑CSF and M‑CSF, in bladder cancer cells: Is G‑CSF a friend of bladder cancer cells?
Hori S; Miyake M; Onishi S; Morizawa Y; Nakai Y; Tatsumi Y; Onishi K; Iida K; Gotoh D; Itami Y; Tanaka N; Fujimoto K
Int J Oncol; 2019 Jun; 54(6):2237-2249. PubMed ID: 31081057
[TBL] [Abstract][Full Text] [Related]
10. Recombinant
Bi Z; Cui E; Yao Y; Chang X; Wang X; Zhang Y; Xu GX; Zhuang H; Hua ZC
Front Microbiol; 2022; 13():927277. PubMed ID: 35847065
[No Abstract] [Full Text] [Related]
11. [Construction of Escherichia coli-Bifidobacterium longum shuttle vector and expression of tumor suppressor gene PTEN in B. longum].
Hou X; Liu JE
Wei Sheng Wu Xue Bao; 2006 Jun; 46(3):347-52. PubMed ID: 16933599
[TBL] [Abstract][Full Text] [Related]
12. Bifidobacteria Expressing Tumstatin Protein for Antitumor Therapy in Tumor-Bearing Mice.
Wei C; Xun AY; Wei XX; Yao J; Wang JY; Shi RY; Yang GH; Li YX; Xu ZL; Lai MG; Zhang R; Wang LS; Zeng WS
Technol Cancer Res Treat; 2016 Jun; 15(3):498-508. PubMed ID: 25969440
[TBL] [Abstract][Full Text] [Related]
13. Enhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer.
Wang R; Qin S; Chen Y; Li Y; Chen C; Wang Z; Zheng R; Wu Q
Oncol Rep; 2012 Aug; 28(2):439-45. PubMed ID: 22641525
[TBL] [Abstract][Full Text] [Related]
14. Non-cryopreserved, limited number (1 or 2) peripheral blood progenitor cell (PBPC) collections following GCSF administration provide adequate hematologic support for high dose chemotherapy.
Bezwoda WR; Dansey R; Seymour L; Glencross D
Hematol Oncol; 1994; 12(3):101-10. PubMed ID: 7525446
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor effect of a novel soluble recombinant human endostatin: administered as a single agent or in combination with chemotherapy agents in mouse tumor models.
Ren Z; Wang Y; Jiang W; Dai W; Jiang Y
PLoS One; 2014; 9(9):e107823. PubMed ID: 25229620
[TBL] [Abstract][Full Text] [Related]
16. Pegylated GCSF Can Be Used With First-Line da-EPOCH-R Without Compromising Dose Intensity, Safety, or Efficacy.
Reddy P; Kanan S; Cowan A; Warren H; Till B; Shadman M; Cassaday R; Press O; Shustov A; Gopal A; Smith SD
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e87-e90. PubMed ID: 28870643
[TBL] [Abstract][Full Text] [Related]
17. Liposome transfected to plasmid-encoding endostatin gene combined with radiotherapy inhibits liver cancer growth in nude mice.
Zheng AQ; Song XR; Yu JM; Wei L; Wang XW
World J Gastroenterol; 2005 Jul; 11(28):4439-42. PubMed ID: 16038050
[TBL] [Abstract][Full Text] [Related]
18. Bifidobacterium as an oral delivery carrier of oxyntomodulin for obesity therapy: inhibitory effects on food intake and body weight in overweight mice.
Long RT; Zeng WS; Chen LY; Guo J; Lin YZ; Huang QS; Luo SQ
Int J Obes (Lond); 2010 Apr; 34(4):712-9. PubMed ID: 20065960
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-colony stimulating factor enhances anti-tumour effect of hyperthermia.
Takada Y; Sato EF; Nakajima T; Hosono M; Tsumura M; Inoue M; Yamada R
Int J Hyperthermia; 2000; 16(3):275-86. PubMed ID: 10830589
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow cell mobilization by the systemic use of granulocyte colony-stimulating factor (GCSF) improves wound bed preparation.
Iwamoto S; Lin X; Ramirez R; Carson P; Fiore D; Goodrich J; Yufit T; Falanga V
Int J Low Extrem Wounds; 2013 Dec; 12(4):256-64. PubMed ID: 24275756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
